Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection

Synthetic long peptides (SLP) for therapeutic vaccination against Hepatitis B virus infection

US Patent 10898567 · Granted Jan 26, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B vi2019
Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B vi2019
Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B vi2019
Synthetic long peptides (SLP) for therapeutic vaccination against hepatitis B vi2019
Peptides, conjugates and method for increasing immunogenicity of a vaccine2016
Monophenols and benzenediols sensitization of immune system against haptenized m2016
Peptides of human Papilloma virus for use in human T cell response inducing comp2008
Isolated peptides derived from mage tumor rejection antigen precursors which com2004
Isolated tumor rejection antigen precursor mage-2 derived peptides and uses ther2000
Isolated tumor rejection antigen precursor MAGE-2 derived peptides, and uses the2000
Induction of antigen specific T-lymphocyte responses by stimulation with peptide1998
Peptides of human P53 protein for use in human T cell response inducing composit1997